POLYSUBSTITUTED IMIDAZOPYRIDINES AS GASTRIC SECRETION INHIBITORS
申请人:——
公开号:US20040106642A1
公开(公告)日:2004-06-03
The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
Alkoxy alkyl carbamates of imidazo(1.2-a)pyridines
申请人:BYK Gulden Lomberg Chemische Fabrik GmbH
公开号:US05719161A1
公开(公告)日:1998-02-17
This invention relates to novel compounds of formula (I) and their therapeutic use in the treatment of gastrointestinal diseases. ##STR1##
这项发明涉及公式(I)的新化合物及其在治疗消化道疾病中的治疗用途。
Tricyclic imidazopyridines
申请人:——
公开号:US20030139412A1
公开(公告)日:2003-07-24
1
Compounds of formula (1), in which the substituents as defined in the description are useful for preventing and treating gastrointestinal disorders.
式(1)中的化合物,在其中定义的取代基对预防和治疗胃肠疾病是有用的。
Alkylated imidazopyridine derivatives
申请人:——
公开号:US20030158193A1
公开(公告)日:2003-08-21
Compounds of the formula 1
1
in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
式子为11的化合物,其中置换基的含义在描述中提到,适用于预防和治疗胃肠道疾病。
Imidazopyridine azolidinones
申请人:Byk Gulden Lomberg Chemische Fabrik GmbH
公开号:US06124313A1
公开(公告)日:2000-09-26
Imidazopyridine-azolidinones are useful for treating or preventing amenable gastro-intestinal ailments.